These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance? Mar J; Rodríguez-Artalejo F J Hypertens; 2001 Jan; 19(1):149-55. PubMed ID: 11204296 [TBL] [Abstract][Full Text] [Related]
11. Utility of a transdermal delivery system for antihypertensive therapy. Part 2. Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA Am J Med; 1991 Jul; 91(1A):57S-60S. PubMed ID: 1907802 [No Abstract] [Full Text] [Related]
13. Compliance with antihypertensive therapy: raising the bar of expectations. Rudd P Am J Manag Care; 1998 Jul; 4(7):957-66. PubMed ID: 10181995 [TBL] [Abstract][Full Text] [Related]
14. What is cost-effectiveness analysis? Evans DB Med J Aust; 1990 Aug; 153(S1):S7-9. PubMed ID: 2116585 [TBL] [Abstract][Full Text] [Related]
17. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial. van der Laan DM; Elders PJ; Boons CC; Bosmans JE; Nijpels G; Hugtenburg JG Trials; 2017 Jan; 18(1):29. PubMed ID: 28103948 [TBL] [Abstract][Full Text] [Related]
19. The role of losartan in cost-effective hypertension control. McIntyre H; Costa FV; Düsing R; Ambrosioni E; Gerth W Curr Med Res Opin; 2002; 18(3):139-45. PubMed ID: 12094823 [TBL] [Abstract][Full Text] [Related]
20. Antihypertensive treatment - navigating between cost, compliance and complications. Conen D Swiss Med Wkly; 2013; 143():w13857. PubMed ID: 24163056 [No Abstract] [Full Text] [Related] [Next] [New Search]